Congress Expands Compounding Investigation To Trade Group
This article was originally published in The Pink Sheet Daily
House Energy and Commerce Committee asks for documents related to the International Academy of Compounding Pharmacists’ role in assisting members with federal and state regulatory interactions.
You may also be interested in...
As meningitis outbreak widens, FDA and members of Congress are calling for clarification of what jurisdiction the agency has over pharmacies, but agency officials are stopping short of asking for clear new authorities.
Only about one-third of biosimilars received a first-cycle approval from US FDA after product quality discussions during the mid-assessment-cycle meeting, according to an interim report on the biosimilar application review program.
First quarter submission volume is the second lowest of the GDUFA era, in part because of BE study problems caused by the pandemic.